Acadian Asset Management LLC X4 Pharmaceuticals, Inc Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.61 - $0.99 $110,781 - $179,792	181,609 New	181,609 $152,000
Q1 2022 May 12, 2022	SELL	$1.48 - $2.58 $84,759 - $147,756	-57,270 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$1.9 - $5.6 $108,813 - $320,712	57,270 New	57,270 $130,000
Q2 2020 Aug 12, 2020	SELL	$7.98 - $10.44 $16,183 - $21,172	-2,028 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$6.03 - $11.01 $12,228 - $22,328	2,028 New	2,028 $20,000

103

99.9M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $54.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.